Alison Mbekeani
Publications by Year
Research Areas
Malaria Research and Control, Trypanosoma species research and implications, Toxoplasma gondii Research Studies, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria(2012)156 cited
- → Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)(2012)109 cited
- → Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy(2017)56 cited
- → Identification, Design and Biological Evaluation of Heterocyclic Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)(2012)54 cited
- → Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine(2018)46 cited
- → Identification of Novel Antimalarial Chemotypes via Chemoinformatic Compound Selection Methods for a High-Throughput Screening Program against the Novel Malarial Target, PfNDH2: Increasing Hit Rate via Virtual Screening Methods(2012)23 cited
- → A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum(2010)20 cited
- → The antifungal Aureobasidin A and an analogue are active against the protozoan parasiteToxoplasma gondiibut do not inhibit sphingolipid biosynthesis(2017)17 cited
- → Mining for natural product antileishmanials in a fungal extract library(2019)14 cited
- → The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis – Corrigendum(2017)5 cited